Literature DB >> 9500610

Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: implications for antiviral therapy.

G Pantaleo1, O J Cohen, T Schacker, M Vaccarezza, C Graziosi, G P Rizzardi, J Kahn, C H Fox, S M Schnittman, D H Schwartz, L Corey, A S Fauci.   

Abstract

Evolutionary patterns of virus replication and distribution in lymphoid tissue during the early phases of HIV infection have not been delineated. Lymph node (LN) biopsies were excised from patients at different times after the estimated time of primary infection. Within 3 months of the acute viral syndrome, HIV was mostly present in individual virus-expressing cells in LNs; trapping of virions in the follicular dendritic cell (FDC) network was minimal or absent, but was the predominant form of HIV detected in LNs of subjects with chronic infection, either recent (4-20 months after primary infection) or long-term (>2-3 years after primary infection). Plasma viremia was significantly higher in patients during the first 3 months than in those recently infected; however, there were no significant differences in the number of virus-expressing cells per square millimeter of LN tissue in these two groups. Numbers of virus-expressing cells in lymphoid tissue were significantly lower in the subjects with long-term infection than in the other two groups. Therefore, during the transition from primary to chronic HIV infection, the level of HIV replication in lymphoid tissue remains elevated despite the fact that viremia is significantly downregulated. These findings have implications for therapeutic strategies in primary HIV infection and in recent seroconvertors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9500610     DOI: 10.1038/nm0398-341

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  36 in total

1.  Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA.

Authors:  G P Rizzardi; R J De Boer; S Hoover; G Tambussi; A Chapuis; N Halkic; P A Bart; V Miller; S Staszewski; D W Notermans; L Perrin; C H Fox; J M Lange; A Lazzarin; G Pantaleo
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

2.  Functional reconstitution of thymopoiesis after human immunodeficiency virus infection.

Authors:  S G Kitchen; S Killian; J V Giorgi; J A Zack
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Initial antiretroviral regimens.

Authors:  Charles Carpenter
Journal:  BMJ       Date:  2002-03-30

4.  Detachment of human immunodeficiency virus type 1 from germinal centers by blocking complement receptor type 2.

Authors:  L Kacani; W M Prodinger; G M Sprinzl; M G Schwendinger; M Spruth; H Stoiber; S Döpper; S Steinhuber; F Steindl; M P Dierich
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.

Authors:  Robert W Shafer; Kathryn Dupnik; Mark A Winters; Susan H Eshleman
Journal:  HIV Seq Compend       Date:  2001

6.  Stress management effects on perceived stress and cervical neoplasia in low-income HIV-infected women.

Authors:  Michael H Antoni; Deidre B Pereira; Ilona Marion; Nicole Ennis; Michele Peake Andrasik; Rachel Rose; Judith McCalla; Trudi Simon; Mary Ann Fletcher; Joseph Lucci; Jonell Efantis-Potter; Mary Jo O'Sullivan
Journal:  J Psychosom Res       Date:  2008-10       Impact factor: 3.006

7.  Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist.

Authors:  Katsunori Takashima; Hiroshi Miyake; Naoyuki Kanzaki; Yoshihiko Tagawa; Xin Wang; Yoshihiro Sugihara; Yuji Iizawa; Masanori Baba
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

8.  Protein kinase Ctheta is a specific target for inhibition of the HIV type 1 replication in CD4+ T lymphocytes.

Authors:  María Rosa López-Huertas; Elena Mateos; Gema Díaz-Gil; Francisco Gómez-Esquer; María Sánchez del Cojo; José Alcamí; Mayte Coiras
Journal:  J Biol Chem       Date:  2011-06-13       Impact factor: 5.157

9.  Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1.

Authors:  Brandon F Keele; Loubna Tazi; Suzanne Gartner; Yiling Liu; Trever B Burgon; Jacob D Estes; Tyler C Thacker; Keith A Crandall; Justin C McArthur; Gregory F Burton
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

10.  Contrasting roles for TLR ligands in HIV-1 pathogenesis.

Authors:  Beda Brichacek; Christophe Vanpouille; Yana Kiselyeva; Angelique Biancotto; Melanie Merbah; Ivan Hirsch; Andrea Lisco; Jean Charles Grivel; Leonid Margolis
Journal:  PLoS One       Date:  2010-09-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.